Leidos Q1 FY26: where the revenue came from and where it went
The whole income statement of Leidos for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jan 3 – Apr 3, 2026
- Reported
- May 5, 2026
Revenue$4.40B
+4% year over year
Gross profit$0.76B
17% margin
Operating profit$0.51B
12% margin
Net profit$0.33B
7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 4.40 | 100% | +4% |
| Health | 1.19 | 27% | |
| Defense | 0.88 | 20% | |
| Homeland | 0.82 | 19% | |
| Commercial & non-U.S. | 0.59 | 13% | |
| Time-&-materials | 0.57 | 13% | |
| International | 0.36 | 8% | |
| Cost of revenue | −3.64 | 83% | |
| Gross profit | 0.76 | 17% margin | −1pp |
| SG&A | −0.22 | 5% | +0pp |
| Other | −0.03 | 1% | +0pp |
| Operating profit | 0.51 | 12% margin | −1pp |
| Interest & other costs | −0.09 | ||
| Tax | −0.09 | ||
| Net profit | 0.33 | 7% margin | −1pp |
140 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest